REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH)

Historical Holders from Q4 2020 to Q3 2025

Symbol
RVPH on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
120,538,577
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
9,455,573
Holdings value
$3,485,209
% of all portfolios
0%
Number of holders
38
Number of buys
16
Number of sells
-21
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 9.9% $3,120,000 8,000,000 HIGHBRIDGE CAPITAL MANAGEMENT, LLC 30 Jun 2025
SAXENA PARAG 5.2% -17% $3,259,363 +$4,264 6,268,006 +0.13% Parag Saxena 18 Dec 2025
683 Capital Management, LLC 5.36% $2,771,850 5,435,000 683 CAPITAL MANAGEMENT, LLC 22 Sep 2025
Bhat Laxminarayan 3.8% -28% $1,877,246 +$34,930 3,680,874 +1.9% Bhat Laxminarayan 22 Sep 2025
CVI Investments, Inc. 4.9% -17% $1,392,925 -$167,075 3,571,603 -11% CVI Investments, Inc. 30 Jun 2025
TANG CAPITAL MANAGEMENT LLC 4.8% -38% $1,325,990 -$199,028 3,399,975 -13% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
Schonfeld Strategic Advisors LLC 2.82% $1,157,125 1,314,915 Schonfeld Strategic Advisors LLC 31 Dec 2024

Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value (RVPH)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 9,455,573 $3,485,209 -$2,522,741 $0.3686 38
2025 Q2 14,276,867 $5,439,564 +$2,030,904 $0.3811 44
2025 Q1 7,316,794 $6,939,218 -$2,147,972 $0.9538 47
2024 Q4 7,732,309 $14,008,817 -$4,024,379 $1.81 42
2024 Q3 9,947,227 $14,936,260 +$4,666,858 $1.44 33
2024 Q2 6,849,687 $8,748,871 +$1,342,404 $1.28 30
2024 Q1 5,573,837 $21,010,997 -$1,861,302 $3.78 28
2023 Q4 5,266,256 $27,119,158 +$12,592,563 $5.15 35
2023 Q3 2,663,385 $13,004,016 -$556,556 $4.88 24
2023 Q2 2,636,201 $15,447,187 +$8,416,328 $5.86 22
2023 Q1 1,375,662 $5,761,612 +$298,180 $4.19 22
2022 Q4 1,303,532 $5,539,575 +$1,730,868 $4.25 23
2022 Q3 865,615 $1,376,000 -$905,812 $1.59 15
2022 Q2 1,865,547 $2,053,000 -$115,802 $1.1 9
2022 Q1 1,902,181 $4,678,000 -$2,054,792 $2.46 14
2021 Q4 2,612,910 $7,543,000 -$15,645 $2.89 11
2021 Q3 2,603,081 $10,549,000 -$229,537 $4.06 11
2021 Q2 2,652,392 $12,779,000 +$9,606,649 $4.86 11
2021 Q1 586,328 $3,365,000 +$1,292,854 $5.74 7
2020 Q4 360,070 $3,149,000 +$3,149,000 $8.77 3